⬆
✘
 
By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,
⌂ /Other products /
 Share

Fitoval maintenance anti-dandruf dermatological shampoo

Compare Prices in pharmacies: 3.9-4.5€
Can't order it
Found partially in the 26 (12) ⓘ✘Found partially in the 26 drugs (12 of these, according to Kiberis statistics) in 0 selected books (authors) ... hide
  Effect Influence Cases ⓘ ✘ Effect - how much the symptom improves in one treatment cycle on average. Example: drug Pain relief for cancer pain-Effectiveness (E) is high, but the effect (I) negative, because the patient will get worse over time.
Influence of the symptom on the outcome of the patient's treatment as a whole (i.e., the importance of the symptom). Example: menopause can not be cured (E low). But some means during menopause will be better than others (I high).
Cases - the number of investigated treatment results for a given complaint, on the basis of which the effect and effect were calculated. These cases have already passed automatic AI verification of data quality and reliability.
  • fitoval maintenance anti-dandruf dermatological shampoo
  •  62%+13%6   Hidden. Need a subscription
    Dandruff - E 62% (I 13%, 6 cases.); Regularly - E 26% (I 0%, 13 cases.)
  •  51%-3%5 read Arsenicum album
    Dandruff - E 51% (I -3%, 5 cases.); Regularly - E 33% (I 5%, 15 cases.)
  •  47%-4%6 read Thuja occidentalis
    Dandruff - E 47% (I -4%, 6 cases.); Regularly - E 28% (I -3%, 17 cases.)
  •  35%+2%9 read Silica terra
  • 33%+11%15 read Sepia officinalis
    Dandruff - E 33% (I 11%, 15 cases.); Regularly - E 50% (I 8%, 11 cases.)

    перхоть,регулярно

    • ⇒ 56% +27% 7 with «allergy»
    • ⇒ 50% +25% 7 with «rashes on the head»
    • On average: 33% 11% 15 
    • ⇒ 15% -2% 5 with «pain in the legs»
    • ⇒ 13% +1% 6 with «sweating is increased»
    • ⇒ 11% -18% 4 with «dry skin»
    • ⇒ 10% +6% 3 with «chilly»
    • ⇒ 9% +0% 4 with «worse from movement»
    • ⇒ 8% +8% 4 with «headaches»
    • ⇒ 5% +9% 4 with «monthly painful»
    • ⇒ 5% -3% 4 with «sensations in the legs»
    • ⇒ 5% -3% 4 with «sensations in the extremities»
    • ⇒ 4% -14% 4 with «swelling»
    • ⇒ 3% -12% 6 with «itchy skin»
    • ⇒ 0% +8% 4 with «abdominal pain»
    • ⇒ 0% +2% 4 with «drowsiness»
  •  33%-6%4 read Mezereum
  •  32%+3%11 read Natrum muriaticum
    Dandruff - E 32% (I 3%, 11 cases.); Regularly - E 29% (I 1%, 29 cases.)
  • 25%-4%8 read Lycopodium clavatum
    Dandruff - E 25% (I -4%, 8 cases.); Regularly - E 33% (I 5%, 20 cases.)

    перхоть,регулярно

    • On average: 25% -4% 8 
    • ⇒ 5% -4% 4 with «likes sweets»
  •  21%+20%5 read Calcarea carbonica
    Dandruff - E 21% (I 20%, 5 cases.); Regularly - E 37% (I -3%, 16 cases.)
  •  18%-18%7 read Phosphorus
    Dandruff - E 18% (I -18%, 7 cases.); Regularly - E 25% (I 2%, 13 cases.)
  •  17%-5%7 read Pulsatilla nigricans
    Dandruff - E 17% (I -5%, 7 cases.); Regularly - E 21% (I -7%, 18 cases.)
  • 12%+2%9 read Sulphur
    Dandruff - E 12% (I 2%, 9 cases.); Regularly - E 30% (I 3%, 20 cases.)

    перхоть,регулярно

    • ⇒ 50% +24% 4 with «rashes on the head»
    • On average: 12% 2% 9 
    • ⇒ -16% -18% 4 with «inflammation»
  •  Baryta carbonica read
  •  Baryta muriatica read
  •  Causticum hahnemanni read
  •  Echinacea compositum sn read
  •  Hepar sulphuris calcareum read
  •  Ignatia amara read
  •  Kalium carbonicum read
  •  Lachesis muta read
  •  Medorrhinum read
  •  Mercurius solubilis read
  •  Mucosa compositum read
  •  Nux vomica read
  •  Rhus toxicodendron read
  •  Staphysagria read
  1. Pharmacological Group
  2. Indications for use
  3. Composition
  4. Pharmacological action
  5. Use during pregnancy and lactation
  6. Method of drug use and dosage
  7. Side effects
  8. Special instructions
  9. Description of the dosage form
  10. Storage conditions
  11. Expiration date
  12. Used in the treatment
  13. Manufacturers of the drug
Fitoval maintenance anti-dandruf dermatological shampoo

Pharmacological Group

Dermatotropic products

Indications for use

 Список кодов МКБ-10.
 • L21,0 Себорея головы.

Composition

Шампунь дерматологический 1 фл.
комплекс цинк-ПT-S (пиритион цинка и экстракт белой ивы (Salix alba), гидроксиэтилмочевина

Pharmacological action

 Фармакологическое действие - противовоспалительное, противогрибковое, противосеборейное.

Use during pregnancy and lactation

 Не рекомендуется использовать средство во время беременности и грудного вскармливания.

Method of drug use and dosage

 Рекомендуется для регулярного мытья волос.
 Нанести шампунь на мокрые волосы и равномерно распределить на коже головы массирующими движениями. Оставить для воздействия на 3 мин, а затем тщательно смыть водой. Повторить процедуру, смыв шампунь сразу после нанесения, не оставляя для воздействия. При попадании в глаза тщательно промыть их большим количеством воды.
 Если через некоторое время перхоть появится снова, рекомендуется повторное использование шампуня для интенсивного или регулярного ухода, в зависимости от степени проявления перхоти.
 При сильной устойчивой перхоти рекомендуется использование шампуня для интенсивного ухода.

Side effects

 При первом применении может возникать ощущение легкого пощипывания кожи головы.

Special instructions

 Средство не рекомендуется применять у детей младше 12 лет.

Description of the dosage form

 Шампунь дерматологический, 200 мл. Во флаконе 200 мл; в пачке картонной 1 фл.

Storage conditions

 Хранить в недоступном для детей месте.

Expiration date

 Не применять по истечении срока годности, указанного на упаковке.

Used in the treatment

Manufacturers (or distributors) of the drug

 
KRKA
42a96bb5c8a2acfb07fc866444b97bf1
✘Available only when using PRO account
Content moderator: Vasin A. S.


  1. Kiberis is NOT an online store and does NOT purchase, store, sell or deliver drugs. The resource acts only as an intermediary between you and the manufacturer of drugs or pharmacy points, which carry out the delivery.
  2. On Kiberis there are descriptions of drugs, some of which are intended only for doctors. This information cannot be used by patients to make decisions about the use of drugs, their cancellation or correction of dosages.
  3. Nothing in the information provided should be interpreted as a call to use these drugs.
  4. No claims can be made to Kiberis regarding any damage or harm incurred as a result of the use of the information posted on the site.